Skip to main content
Clinical Trials/NL-OMON44830
NL-OMON44830
Completed
Not Applicable

Prevalence of gastrointestinal disorders in the general population 50 to 75 years in the Ommoord municipality: videocapsule in the Rotterdam study - Videocapsule-ERGO

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
celiac disease
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
1000
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- 50\-74 years
  • \- participant Rotterdam study

Exclusion Criteria

  • \- Inability or refusal to provide informed consent.
  • \- Persons with a severe or terminal disease with a life\-expectancy of less than 5 years.
  • \- An allergy or any other known contraindication to the medication used in this study
  • \- Renal failure, eGFR \<30 ml/min/1\.73m2
  • \- Congestive heart failure NYHA class III or IV
  • \- Dysphagia or other swallowing disorder which makes it impossible to swallow the capsule.
  • \- High risk of capsule retention: IBD, Personal history of gastrointestinal surgery other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator.
  • \- Cardiac pacemakers or other implanted electro\-medical equipment.
  • \- An MRI scheduled within 14 days after ingestion of the capsule.
  • \- Patients with diagnosed or suspected Congenital Long QT Syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials